ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

We aren’t showing our typical comparisons because the provider updated his/her state of practice after we conducted our analysis. The updated address appears on this page.

Nurse Practitioner, Adult Health

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,174Medicare Part D Prescriptions Filled, Including Refills
$401K Total Retail Price of All Prescriptions
448 Patients Receiving at Least One Drug in Part D
83%Patients 65 Years and Older
62% Subsidized Claims for Low-Income Patients

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume .

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category
LEVOTHYROXINE SODIUM 572 544
HYDROCODONE-ACETAMINOPHEN 356 325 S3
CITALOPRAM HBR 302 301
FUROSEMIDE 292 272
LISINOPRIL 262 257
OMEPRAZOLE 237 226
FENTANYL 215 184 S2
POTASSIUM CHLORIDE 202 191
METOPROLOL TARTRATE 199 176
METFORMIN HCL 180 178
GABAPENTIN 178 115
HYDROCHLOROTHIAZIDE 176 153
METOPROLOL SUCCINATE 174 162
AMLODIPINE BESYLATE 166 156
LACTULOSE 163 149
DONEPEZIL HCL 161 161
TRAZODONE HCL 132 112
PRAVASTATIN SODIUM 130 111
SERTRALINE HCL 127 124
WARFARIN SODIUM 126 109
RISPERIDONE 106 106
MIRTAZAPINE 103 103
SIMVASTATIN 90 85
ALENDRONATE SODIUM 89 72
POLYETHYLENE GLYCOL 3350 85 62
CIPROFLOXACIN HCL 83 79
ALBUTEROL SULFATE 82 77
TRAMADOL HCL 76 76
ZOLPIDEM TARTRATE 74 63
ATORVASTATIN CALCIUM 72 67
DIGOXIN 71 58
NAMENDA 68 68
ROPINIROLE HCL 66 60
MORPHINE SULFATE ER 65 47 S2
IPRATROPIUM-ALBUTEROL 63 63
DIOVAN 60 60
SULFAMETHOXAZOLE-TRIMETHOPRIM 55 51
OXYBUTYNIN CHLORIDE 54 54
CLONIDINE HCL 53 51
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Sept. 23, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.